Krensavage Asset Management, LLC: summary

Krensavage Asset Management, LLC reported 18 positions with a reported value of $263.2K in its 13F for Q2 2026. Compared with Q1 2026: 0 new positions, 2 exited.

Top positions

• Enanta Pharmaceuticals Inc
• JAZZ PHARMACEUTICALS PLC
• UNITED THERAPEUTICS CORP DEL COM
• BioMarin Pharmaceutical Inc
• EXELIXIS INC COM
• ABBOTT LABORATORIES COM
• SANOFI SA SPONSORED ADR
• Supernus Pharmaceuticals Inc
• Ultragenyx Pharmaceutical Inc
• Vanda Pharmaceuticals Inc